Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01JCJ
|
|||
| Former ID |
DNC013503
|
|||
| Drug Name |
1-(oxazolo[4,5-b]pyridin-2-yl)octan-1-one
|
|||
| Synonyms |
CHEMBL257305; SCHEMBL3966136; BDBM50350545
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H18N2O2
|
|||
| Canonical SMILES |
CCCCCCCC(=O)C1=NC2=C(O1)C=CC=N2
|
|||
| InChI |
1S/C14H18N2O2/c1-2-3-4-5-6-8-11(17)14-16-13-12(18-14)9-7-10-15-13/h7,9-10H,2-6,8H2,1H3
|
|||
| InChIKey |
HTWHWGPGIJSJQP-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Inhibitors of proteases and amide hydrolases that employ an alpha-ketoheterocycle as a key enabling functionality. Bioorg Med Chem. 2008 Feb 15;16(4):1562-95. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.